Chengdu Olymvax Biopharmaceuticals, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 25.37% vs 35.13% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 10.78% vs 7,750.00% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "201.10",
          "val2": "160.40",
          "chgp": "25.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "43.30",
          "val2": "44.10",
          "chgp": "-1.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.40",
          "val2": "4.00",
          "chgp": "-15.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "33.90",
          "val2": "30.60",
          "chgp": "10.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "215.50%",
          "val2": "217.70%",
          "chgp": "-0.22%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 18.83% vs -9.12% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 37.72% vs -57.14% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "587.40",
          "val2": "494.30",
          "chgp": "18.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "57.40",
          "val2": "37.60",
          "chgp": "52.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "14.50",
          "val2": "7.20",
          "chgp": "101.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "15.70",
          "val2": "11.40",
          "chgp": "37.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "36.50%",
          "val2": "7.40%",
          "chgp": "2.91%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

201.10

160.40

25.37%

Operating Profit (PBDIT) excl Other Income

43.30

44.10

-1.81%

Interest

3.40

4.00

-15.00%

Exceptional Items

0.00

0.00

Consolidate Net Profit

33.90

30.60

10.78%

Operating Profit Margin (Excl OI)

215.50%

217.70%

-0.22%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 25.37% vs 35.13% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 10.78% vs 7,750.00% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

587.40

494.30

18.83%

Operating Profit (PBDIT) excl Other Income

57.40

37.60

52.66%

Interest

14.50

7.20

101.39%

Exceptional Items

0.00

0.00

Consolidate Net Profit

15.70

11.40

37.72%

Operating Profit Margin (Excl OI)

36.50%

7.40%

2.91%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 18.83% vs -9.12% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 37.72% vs -57.14% in Dec 2023

All Annual Results